Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 60760-866

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 60760-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

866-30 (Quetiapine 60760 866 30)

866-30 (Quetiapine 60760 866 30)
This text contains information about a medication labeled as "Quetiapine Extended-Release Tablets, USP 200mg" with a quantity of 30 tablets. The manufacturer is listed as ScieGen Pharmaceuticals Inc. The medication should be stored at a controlled room temperature of 15°-30°C (59°-86°F). The text also includes a prescription number, lot numbers, and expiration dates. The text further indicates that the medication should be used as directed. Additionally, it mentions the packaging location in Oro Valley, AZ.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

FDA Label Image

Structural Formula (Quetiapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.